Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...
Emergen Research Logo As global demand for bio-based materials continues to rise, nanocellulose is poised to play a crucial role in various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results